Sidekick, a Berlin, Germany, NYC, Kopavogur, Iceland, and Gothenburg, Sweden-based digital therapeutics company, raised $55M in Series B funding.
The round was led by Novator Ventures, with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor that will be revealed at a later stage. Novator Ventures general partner and founder Birgir Mar Ragnarsson joined Sidekick’s board of directors in conjunction with the closing of the Series B financing.
Click here to read the press release
Target – Sidekick Health GmbH
Buyer – NOVATOR PARTNERS LLP
Buyer – Wellington Partners Advisory AG
Buyer – ASABYS PARTNERS SGEIC
Buyer – Frumtak Ventures
Seller – Shareholders
